How Your Lab Can Play a Role


Using the appropriate SARS-CoV-2 CE-IVD marked test, your lab can easily pivot from diagnostics, to screening asymptomatic individuals. We can help you get there by immediate deployment of solutions you need. According to the FDA companion resource, a highly sensitive RT-PCR test should be used for screening asymptomatic individuals without known exposure to SARS-CoV-21.

A highly sensitive RT-PCR test for screening asymptomatic individuals

The PerkinElmer SARS-CoV-2 Real-time RT-PCR CE-Marked Assay has the same formulation as the PerkinElmer New Coronavirus Nucleic Acid Detection Kit which is the most sensitive, commercially available COVID-19 molecular diagnostic test authorized for emergency use, as reported by FDA’s reference panel study2.

Saliva is a desirable as a specimen type for SARS-CoV-2 testing because collecting saliva is much easier and less invasive than collecting other sample types. Not only is saliva collection easier, it is also faster, more scalable than swab collection, and also reduces health care workers’ exposure to sick patients. Note that saliva samples need to be collected under observation or by a healthcare provider. A complete automated workflow is also available for testing of saliva samples.

PerkinElmer, Inc. is one of the few entities that manufactures a molecular diagnostic test kit to screen pooled asymptomatic individuals – this capability is at the very heart of a successful COVID-19 testing program1.

Pooling reduces costs for COVID-19 screening


  1. FDA. A Closer Look at Coronavirus Disease 2019 (COVID-19) Diagnostic Testing
  2. Lowest limit of detection and most sensitive reflect a comparison of analytical sensitivity between Emergency Use Authorized COVID test kits as reported in FDA SARS-CoV-2 Reference Panel on October 7, 2021.

Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.